focus -WSS

focus

author：focus 2025-10-06 11:31:12 - browse：54

Outgoing Bristol CEO Giovanni Caforio Emilie Pickering for STAT

It’s changing of the guard time at pharmaceutical giant Bristol Myers Squibb. On Wednesday, CEO Giovanni Caforio will step down. He’ll be replaced by Christopher Boerner, who is currently chief operating officer.

When Caforio took over in May 2015, Bristol was known as a big pharmaceutical firm with the high-flying stock of a biotechnology company, largely due to its role as the company that brought cancer immunotherapy to market. But Bristol stumbled in 2016 when its immunotherapy Opdivo failed to help patients with non-small cell cancer more than chemotherapy. Opdivo remained a big seller, but its failure allowed Merck’s rival Keytruda to move into position to become the best-selling medicine in the world. In 2019, Caforio tried to flip the script, buying the biotech Celgene for $74 billion.

STAT recently sat down with Caforio, 59, to look back on what went wrong and right with his tenure. He also reflected on what it meant to be a physician — and the son of a physician. “We were speaking about patient stories over lunch and dinner, when I was a kid, and I think that drove my passion for medicine,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Menendez indictment could see pharma lose a key ally

leisure time

entertainment

WSS

First medicine developed to treat MASH expected to be approved soon

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

With psoriasis trial ahead, Alumis raises $259 million

Amylyx ALS drug failure raises questions and concerns

Headspace, Meta partner to launch VR meditation app for Quest

Headspace, Meta partner to launch VR meditation app for Quest

focus

focus

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

FDA seeks to regulate lab

Duchenne breakthrough therapy leaves behind pioneering families

Precocious puberty in girls comes with mental health risks

Heart attack and stroke risk calculators need revising

UnitedHealth quietly bought dozens of outpatient centers

Dobbs anniversary: the lost opportunity of abortion as health care

Paxlovid should be available without a positive Covid test

George Santos makes 1st court appearance after pleading not guilty to 13 counts

After a drawn out lobbying fight, ARPA

entertainment

WHO recommends dropping component of many flu vaccines

How one patient went off dialysis — and others can too

The problem with charging patients to message their doctors

Sudafed saga points to U.S. issues with evaluating older drugs

Ionis has late

What it’s like to watch children die of measles

leisure time

entertainment

focus

knowledge